US Peptide Companies 2026: How to Vet Suppliers

The single most useful thing a researcher can do before buying from any supplier takes about ten minutes: ask for the certificate of analysis for the specific lot number you'd receive, not a generic sample COA posted years ago. That one request separates US peptide companies that run per-lot third-party testing from those that test occasionally and reuse the paperwork. All products are sold for laboratory research use only and are not for human consumption.

We publish this as Real Peptides, a US-based research peptide supplier. We're included in the comparison below and we've been explicit about where our model has limits. Our team has worked with laboratory buyers long enough to know that the questions that actually predict quality are boring ones about documentation, not marketing claims about purity.

What should researchers look for in us peptide companies?

The strongest signals from us peptide companies are per-lot third-party certificates of analysis tied to the exact lot shipped, verifiable domestic synthesis or fulfillment, published CAS numbers and molecular weights, and research-use-only labeling. Domestic operations also remove customs seizure risk entirely. Start by requesting a lot-specific COA before ordering.

Here's the misconception worth correcting early: "made in the USA" and "shipped from the USA" are not the same claim, and many suppliers blur the two deliberately. A company can import bulk lyophilised powder, vial and label it domestically, and truthfully say it ships from a US facility. That's not fraud, but it's a different quality chain than domestic synthesis. This article covers the four-part vetting methodology we use, what a COA actually has to contain to mean anything, how domestic and overseas supply chains differ in practice, and the scenarios researchers hit most often.

The four checks that separate real suppliers from resellers

Four things predict supplier reliability better than anything else on a website: per-lot third-party testing, verifiable US operations, documented shipping and cold-chain handling, and plain transparency about what the company does and doesn't do. Everything else is noise.

Per-lot third-party testing. The meaningful version is a certificate of analysis generated by an independent analytical lab for the specific batch you receive, identified by lot number. It should report purity by HPLC (high-performance liquid chromatography, which separates the target peptide from truncated sequences and synthesis byproducts) and identity by mass spectrometry, which confirms the molecular weight matches the intended amino-acid sequence. A COA with no lot number, no lab name, and no date is a marketing graphic.

Verifiable US operations. Look for a physical address, a stated business entity, and a support channel staffed by people who can answer a technical question about CAS number or molecular formula. Real Peptides publishes its operations and location details and its certificates of analysis rather than gating them behind a support ticket.

Shipping and handling. Lyophilised peptides are relatively stable as dry powder, but they're hygroscopic and degrade with repeated temperature cycling. Ask how material is packed and how quickly it moves.

Transparency. A supplier that tells you what it doesn't test for is more credible than one claiming universal 99%+ purity across a 60-compound catalog. We've reviewed enough supplier documentation to say that confidently.

What a certificate of analysis actually has to contain

A usable COA names the compound, the lot number, the test date, the analytical methods used, the measured purity value, and the testing laboratory. If any of those six fields is missing, the document can't be verified and shouldn't change your purchasing decision.

This is where most us peptide companies get separated from each other. The HPLC chromatogram matters more than the headline purity number, because the number alone tells you nothing about what the remaining fraction is. A peptide reported at 98% purity where the 2% is residual trifluoroacetic acid from purification is a different material than 98% where the balance is a deletion sequence missing one amino acid. Deletion sequences are structurally similar enough to confound binding studies without being obvious in the assay.

The mistake we see most often isn't buying from a bad supplier. It's buying from a reasonable supplier and never matching the vial's printed lot number against the COA on file. Those two numbers disagree more often than you'd expect, usually from fulfillment error rather than deception, and nobody catches it because nobody checks. That check costs thirty seconds.

Also verify the CAS number and molecular weight independently before procurement. BPC-157 and TB-500 have distinct registry identifiers and formulas; a supplier listing the wrong one for a compound has a documentation control problem that probably isn't isolated to the website. Our catalog lists CAS and molecular identity data per compound, including for BPC-157 and TB-500, so researchers can cross-check before ordering rather than after.

Real Peptides does not provide preparation or administration guidance of any kind. These are research-use-only compounds, and the relevant framework for a laboratory is concentration math: milligrams of peptide per milliliter of solvent, read directly off the certificate's stated vial content.

Domestic supply chains versus overseas sourcing

The practical difference between domestic and overseas research peptide sourcing is customs. Material shipped internationally can be held, inspected, or seized, and a package sitting in a customs facility for three weeks has experienced temperature conditions nobody documented. Domestic shipping removes that variable completely.

There's a second difference that gets less attention: recourse. When a lot arrives with a COA that doesn't match the label, a US-operating supplier is a business you can contact, escalate with, and resolve against. An overseas vendor reachable only through a messaging app is not. Our team has watched researchers lose entire experimental timelines to this, not because the compound was bad but because the replacement took six weeks.

Peptides made in USA facilities aren't automatically superior chemistry. Solid-phase peptide synthesis is a mature, well-characterised process, and competent manufacturers exist in many countries. What domestic operations change is verifiability and speed of resolution. That's the honest framing.

Small-batch synthesis matters here too. Large bulk lots sit in inventory longer, and lyophilised peptide stored for extended periods under inconsistent conditions accumulates degradation that a COA dated eighteen months earlier won't reflect. Smaller, more frequent synthesis runs mean the certificate is closer in time to the material you receive. That's the model Real Peptides runs across its research peptide catalog, including compounds like Ipamorelin, CJC-1295 No DAC, and GHK-Cu.

All compounds referenced throughout this article are supplied for laboratory research use only.

Research peptide supplier comparison: what to check and why

This table maps the four methodology criteria against what each signal actually tells you and what a weak version of it looks like. Use it as a checklist against any supplier's public site, including ours.

What If: Common Supplier Scenarios

What if the COA I receive has a different lot number than my vial?

Contact the supplier and request the correct lot documentation before using the material in any work. A mismatch is usually a fulfillment or filing error rather than substitution, but you cannot characterise the compound you have using a certificate that describes a different batch. Any supplier running proper documentation control can produce the right COA within a business day. If they can't, or they tell you the lots are equivalent, that's a quality system failure worth treating as disqualifying.

What if a supplier only publishes in-house testing results?

Treat in-house results as a weaker but not worthless signal, and ask directly whether independent verification is available on request. Manufacturer-run HPLC is legitimate analytical chemistry, but it has an obvious incentive structure problem. Independent third-party labs have no stake in the result. Several us peptide companies run both, using in-house testing for process control and third-party testing for release documentation, which is the stronger arrangement.

What if the compound arrives looking different from the last lot?

Document the appearance, photograph it, and contact the supplier before proceeding. Lyophilised peptide cake appearance varies legitimately between runs depending on fill volume, freeze-drying cycle, and the specific peptide's physical properties, so a different-looking cake is not automatically a problem. What is a problem is visible discoloration, a collapsed or oily cake, or moisture inside the vial, which suggests seal failure or temperature excursion in transit.

What if I need documentation for an institutional purchasing review?

Ask the supplier for its research-use-only labeling policy in writing alongside the lot COA. Institutional procurement and EHS reviews typically want the compound identity documentation, intended-use labeling, and a traceable supplier entity. Suppliers that publish COAs openly, as on the Real Peptides COA page, make this substantially faster than those requiring a support request per lot.

The uncomfortable truth about purity claims

Here's the honest answer: the purity percentage printed on most research peptide websites is close to meaningless as a comparison tool between us peptide companies. Nearly everyone claims 98% or 99%. The number is cheap to state and expensive to verify, which is exactly why it's the most-advertised metric in the category.

What's actually comparable is documentation discipline. Does the lot number on the vial match the COA? Is the testing lab named? Is the test date within a reasonable window of synthesis? Those questions have verifiable answers. Purity claims without a chromatogram behind them don't.

The researchers who get consistent results aren't the ones chasing the highest advertised purity figure. They're the ones who standardise on suppliers whose paperwork holds up when checked.

Building a repeatable procurement standard

The most effective thing a lab can do is write its supplier criteria down once and apply them identically every time, rather than re-evaluating under deadline pressure when a compound is needed next week. Deadline procurement is where standards quietly collapse.

A workable standard has four lines: lot-specific third-party COA required before release to the bench; CAS number and molecular weight verified against an independent reference; supplier must have a verifiable physical US entity; and research-use-only labeling must be present on the vial and the paperwork. Compounds across our catalog, including MOTS-c, Tesamorelin, and KPV, are supplied against that documentation model.

One nuance most guides miss entirely: run your verification on a low-stakes order first. Buying a single inexpensive compound purely to test a supplier's documentation, response time, and packing before committing a real procurement budget costs very little and tells you more than any amount of website evaluation. We've seen labs standardise on suppliers they'd never tested this way, then discover the documentation gap mid-study.

The literature on individual research peptides varies enormously in maturity, and no supplier claim substitutes for reading it. Studies report findings in specific models under specific conditions; translation beyond that is not established. Real Peptides supplies these compounds for laboratory research use only, not for human consumption, and provides no guidance on preparation or administration.

For researchers comparing options, the full Real Peptides catalog, published certificates of analysis, and company operations information are all publicly accessible without an account.

When researchers compare us peptide companies on the things that are easy to compare, they end up comparing marketing copy. The suppliers worth working with are often not the loudest ones, and the tell is almost always administrative rather than scientific: whether the lot number matches, whether the lab is named, whether someone answers a technical question with a technical answer. Chemistry you can't verify isn't data. It's a purchase you're hoping went well, and hope is a poor control variable in any study.